These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 30293082

  • 1. The Effect of Autoantibody against M2-Muscarinic Acetylcholine Receptor in Heart Failure Patients on Digoxin Treatment.
    Hou D, Fan Z, Xu L, Wang H, Zhang Z, Ma G, Xu X, Wang X, Zhang J, Liu J, Zhang L.
    Cardiology; 2018; 141(1):9-17. PubMed ID: 30293082
    [Abstract] [Full Text] [Related]

  • 2. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
    Miao GB, Liu JC, Liu MB, Wu JL, Zhang G, Chang J, Zhang L.
    Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
    [Abstract] [Full Text] [Related]

  • 3. Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatment.
    Ma G, Chen L, Yue Y, Liu X, Wang Y, Shi C, Song F, Shi W, Lo Y, Zhang L.
    BMC Cardiovasc Disord; 2021 Dec 28; 21(1):619. PubMed ID: 34963460
    [Abstract] [Full Text] [Related]

  • 4. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP, Wu JL, Fan Q, Liu MB, Yin BL, Zhang L.
    Clin Sci (Lond); 2007 Mar 28; 112(5):299-304. PubMed ID: 17020540
    [Abstract] [Full Text] [Related]

  • 5. Association of autoantibodies against the M2-muscarinic receptor with long-term outcomes in peripartum cardiomyopathy patients: A 5-year prospective study.
    Ma G, Wang Y, Hou D, Liu J, Zhang J, Xu L, Wang H, Zhao W, Zhang Y, Zhang L.
    J Cardiol; 2019 Sep 28; 74(3):251-257. PubMed ID: 30878354
    [Abstract] [Full Text] [Related]

  • 6. Clinical benefits of low serum digoxin concentrations in heart failure.
    Adams KF, Gheorghiade M, Uretsky BF, Patterson JH, Schwartz TA, Young JB.
    J Am Coll Cardiol; 2002 Mar 20; 39(6):946-53. PubMed ID: 11897434
    [Abstract] [Full Text] [Related]

  • 7. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM.
    JAMA; 2003 Feb 19; 289(7):871-8. PubMed ID: 12588271
    [Abstract] [Full Text] [Related]

  • 8. Perindopril treatment promote left ventricle remodeling in patients with heart failure screened positive for autoantibodies against angiotensin II type 1 receptor.
    Du Q, Wu J, Wang H, Wang X, Xu L, Zhang Z, Liu J, Zhang J, Chen J, Hakonarson H, Hu A, Zhang L.
    BMC Cardiovasc Disord; 2013 Oct 31; 13():94. PubMed ID: 24175973
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y.
    Eur J Clin Pharmacol; 2001 Apr 31; 57(1):77-83. PubMed ID: 11372597
    [Abstract] [Full Text] [Related]

  • 12. Mitochondrial Ultrastructural Alterations and Declined M2 Receptor Density Were Involved in Cardiac Dysfunction in Rats after Long Term Treatment with Autoantibodies against M2 Muscarinic Receptor.
    Zhang S, He Z, Wang J, Wang L, Wu Y, Wang J, Lv T, Liu H.
    PLoS One; 2015 Apr 31; 10(6):e0129563. PubMed ID: 26086781
    [Abstract] [Full Text] [Related]

  • 13. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A.
    Pol Arch Med Wewn; 2001 Jun 31; 105(6):475-82. PubMed ID: 11865578
    [Abstract] [Full Text] [Related]

  • 14. Association of β1-Adrenergic, M2-Muscarinic Receptor Autoantibody with Occurrence and Development of Nonvalvular Atrial Fibrillation.
    Hu B, Sun Y, Li S, Sun J, Liu T, Wu Z, Feng LI.
    Pacing Clin Electrophysiol; 2016 Dec 31; 39(12):1379-1387. PubMed ID: 27862036
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
    J Cardiovasc Pharmacol; 2015 May 31; 65(5):480-4. PubMed ID: 25945865
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting.
    Orrico KB, Wu M, Wilson AR.
    J Manag Care Pharm; 2011 Nov 31; 17(9):695-700. PubMed ID: 22050394
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
    Ahmed A, Rich MW, Love TE, Lloyd-Jones DM, Aban IB, Colucci WS, Adams KF, Gheorghiade M.
    Eur Heart J; 2006 Jan 31; 27(2):178-86. PubMed ID: 16339157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.